McLean Hospital 115 Mill Street Belmont, MA 02478
The Alcohol and Drug Abuse Inpatient Program takes a comprehensive and multifaceted approach to substance abuse care, using evidence-based treatment methods. Working in close partnership with patients and families, we focus on creating a customized treatment plan for each individual based on his or her specific symptoms, the severity of the symptoms, and other co-occurring psychiatric diagnoses. We encourage family involvement, and with the permission of the patient, family members can be included in assessment, treatment, and aftercare planning.
Our program provides structured, safe detoxification for adults with substance use disorders including the misuse of alcohol, cocaine, or prescription opiate drugs such as Oxycontin or Percocet. This level of care is used for crisis stabilization when there is risk of harm to self or others. With the highest quality medical and psychiatric resources, we provide 24-hour nursing supervision and care in a secure setting. Treatment plans regularly include a combination of individual and group therapies, a variety of treatment models, and medications that help patients manage their symptoms and transition back to their daily lives.
Our patients begin their care in McLean’s Clinical Evaluation Center, where all inpatients are evaluated and then admitted to the program that best suits their symptoms and diagnoses. Upon admission to our program, each patient undergoes a comprehensive diagnostic assessment focusing on drug and alcohol use which is administered by our treatment team and includes psychosocial evaluation, medication evaluation, and assessment of substance use and medical history. Our short-term care focuses on stabilization and aftercare planning to ensure patients are on a path towards recovery.
Through structured schedules, group and individual therapy helps patients become more open and willing to participate in treatment, decreases behavioral symptoms, increases normalized family, work, and social functioning, and emphasizes education and support. Stressing recovery and relapse prevention, we utilize a number of therapy models informed by psychiatric research conducted by investigators within the Division of Alcohol and Drug Abuse, throughout the hospital, and around the world.
Integrated group therapy is an evidence-based treatment for co-occurring bipolar and substance use disorders, developed by McLean’s Roger D. Weiss, MD, and Hilary S. Connery, MD, PhD, and is designed to teach essential recovery behaviors and relapse prevention skills that apply to both illnesses.
Relapse prevention therapy, a form of cognitive behavioral therapy, incorporates self-control, identifying positive and negative consequences and high-risk situations, and implementing coping strategies in order to help patients maintain abstinence.
We also use other treatment modalities such as dialectical behavior therapy (DBT) which emphasizes the development of four skill sets: mindfulness, interpersonal effectiveness, emotion regulation, and distress tolerance, as well as motivational enhancement therapy, which is a counseling approach that helps individuals resolve their ambivalence about engaging in treatment and ceasing drug and alcohol use by evoking rapid and internally motivated change.
Each patient works with a behavioral therapist (a licensed psychologist or clinical social worker). The therapist develops a plan that serves as a guideline for staff to ensure quality and consistency in treatment. Patients meet with a psychiatrist weekly, or more frequently if required, for medication management. Our nursing and counseling staff are also certified in medication administration.
We also encourage patients to seek peer support from organizations such as Alcoholics Anonymous and Narcotics Anonymous, many of which offer self-help groups on McLean’s campus and other nearby areas.